Abstract:Background Cholangiocarcinoma (CCA) is reported as an aggressive cancer which leads to high mortality and no effective therapeutic target has yet been discovered. Surgical resection is the main method to treat patients with CCA. However, only one-third of CCA patients have the opportunity to accept the operation, leading to poor prognosis for CCA patients. Therefore, it is necessary to search for new therapeutic targets of CCA or core genes involved in the happening and growth of CCA. Aim In this study, we utilized bioinformatics technology and accessed to several medical databases trying to find the core genes of CCA for the purpose of intervening CCA through figuring out an effective curative target. Methods Firstly, three differentially expressed genes (DEGs) were discovered from GEPIA, and by further observing the distribution and gene expression, CHST4 was obtained as the core gene. Afterwards, correlated genes of CHST4 in CCA were identified using UALCAN to construct a gene expression profile. We obtained PPI network by Search Tool for the Retrieval of Interacting Networks Genes (STRING) and screened core genes using cytoscape software. Functional enrichment analyses were carried out and the expression of CHST in human tissues and tumors was observed. Finally, a CCA model was established for qPCR and staining validation. Results Three differentially expressed genes (DEGs), CHST4, MBOAT4 and RP11-525K10.3, were obtained. All were more over-expressed in CCA samples than the normal, among which the change multiple and the gene expression difference of CHST4 was the most obvious. Therefore, CHST4 was selected as the core gene. We can see in our established protein–protein interaction (PPI) network that CHST4 had the highest degree of connectivity, demonstrating its close association with CCA. We found that genes were mainly enriched in CCs in the PPI networks genes which shows functional enrichment analysis results, including golgi lumen, extracellular space and extracellular region. CHST4 was found very specifically expressed in the bile duct and was significantly different from that in normal tissues. The overexpression of CHST4 was further verified in the established animal model of TAA-induced CCA in rats. Quantitative PCR (qPCR) demonstrated that CHST4 was significantly overexpressed in tumor tissues, verifying the role of CHST4 as the core gene of CCA. Conclusion CHST4 was increasingly expressed in CCA and CHST4 is worth being studied much further in the intervention of CCA.

Abstract 5440: TM4SF1 maintains cancer stemness in cholangiocarcinoma

Abstract PO-037: Characterization of stemness and immunogenicity of cancer stem cells of intrahepatic cholangiocarcinoma

TM4SF1 promotes EMT and cancer stemness via the Wnt/β-catenin/SOX2 pathway in colorectal cancer

Abstract 3808: TM4SF1 Regulates Cell Cycle and ROS Status in Bladder Cancer Cells by Targeting FOXO3a Via PPARγ-SIRT1 Negative Feedback Loop

TM4SF1 upregulates MYH9 to activate the NOTCH pathway to promote cancer stemness and lenvatinib resistance in HCC

Abstract 2895: Octamer-4/microRNA-1246 Signaling Axis Drives Wnt/β-catenin Activation in Liver Cancer Stem Cells

Abstract 1515: Tertiary lymphoid structures restrain cancer evolution by supporting stem-like CD8+ T cells for sustained anti-tumor immunity

Abstract 1995: the Functional Analyses of Oct4 in Metastasis of Human Hepatocellular Carcinoma

Integrated Analysis of Bulk and Single Cell Datasets with Experimental Validation of Cancer Stemness Function in Thyroid Cancer Prognosis and Immunotherapy

A gene signature is critical for intrahepatic cholangiocarcinoma stem cell self-renewal and chemotherapeutic response

Transmembrane-4 L-six Family Member-1 (TM4SF1) Promotes Non-Small Cell Lung Cancer Proliferation, Invasion and Chemo-Resistance Through Regulating the DDR1/Akt/ERK-mTOR Axis

High-CLDN4 ESCC cells harbor stem-like properties and indicate for poor concurrent chemoradiation therapy response in esophageal squamous cell carcinoma

Abstract 7065: AMBRA1 coordinates mitochondrial function to regulate cancer stemness and tumorigenesis in hepatocellular carcinoma

TFCP2L1 drives stemness and enhances their resistance to Sorafenib treatment by modulating the NANOG/STAT3 pathway in hepatocellular carcinoma

Clinicopathological and prognostic significance of TM4SF5 in colorectal cancer

Octamer-4/Microrna-1246 Signaling Axis Drives Wnt/Beta-Catenin Activation In Liver Cancer Stem Cells

Transmembrane and coiled-coil domain family 3 (TMCC3) regulates breast cancer stem cell and AKT activation

Single-cell RNA sequencing reveals cancer stem-like cells and dynamics in tumor microenvironment during cholangiocarcinoma progression

Toll Like Receptor 4 Facilitates Invasion and Migration As A Cancer Stem Cell Marker in Hepatocellular Carcinoma

CHST4 might promote the malignancy of cholangiocarcinoma

TM4SF1 Regulates Pancreatic Cancer Migration and Invasion in Vitro and in Vivo